Evidence map›Paper›PMID 39872128›Full record

ArticleResearch (Washington, D.C.)2025

Mesenchymal Stem Cells Carrying Viral Fusogenic Protein p14 to Treat Solid Tumors by Inducing Cell-Cell Fusion and Immune Activation.

Yao Wang, Xunlei Pang, Ruirui Li, Jiuzhou Chen, Chen Wen, Huihuang Zhu, Tingyu Long, Jianjie Li, Lijun Zheng, Youcai Deng and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yao WangCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Xunlei PangCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Ruirui LiCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Jiuzhou ChenDepartment of Radiation Oncology, the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China.
Chen WenCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Huihuang ZhuCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Tingyu LongCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Jianjie LiCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Lijun ZhengCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Youcai DengDepartment of Clinical Hematology, College of Pharmacy and Laboratory Medicine Science, Army Medical University, Chongqing 400038, China.
Junnian ZhengCenter of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
Bo XuCancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.ORCID https://orcid.org/0009-0001-4690-4414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39872128
PMCPMC11770199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.